According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is โน298.36. In 2022 the company made an earnings per share (EPS) of โน722.80 an increase over its 2021 EPS that were of โน255.05.
Year | EPS | Change |
---|---|---|
2023 (TTM) | โน288.92 | -60.03% |
2022 | โน722.80 | 183.39% |
2021 | โน255.05 | -17.83% |
2020 | โน310.41 | 21.82% |
2019 | โน254.81 | 23.91% |
2018 | โน205.64 | 141.48% |
2017 | โน85.16 | 64.6% |
2016 | โน51.74 | -90.64% |
2015 | โน552.66 | 178.14% |
2014 | โน198.70 | -48.16% |
2013 | โน383.28 | 22.63% |
2012 | โน312.56 | -11.32% |
2011 | โน352.44 | 230.25% |
2010 | โน106.72 | -70.98% |
2009 | โน367.80 | 6.76% |
2008 | โน344.52 | -15.14% |
2007 | โน405.98 | 7.82% |
2006 | โน376.53 | 19.61% |
2005 | โน314.80 | 18.56% |
2004 | โน265.51 | 0.36% |
2003 | โน264.57 | 50.39% |
2002 | โน175.92 | 31.13% |
2001 | โน134.15 | -25.43% |
2000 | โน179.91 | 31.58% |
1999 | โน136.73 | 1.05% |
1998 | โน135.31 | -0.98% |
1997 | โน136.65 | -10.07% |
1996 | โน151.96 |